Efficacy of the Combined Intrastromal Injection of Voriconazole and Amphotericin B in Recalcitrant Fungal Keratitis.
Antonello MoramarcoArianna GrendeleDanilo IannettaSimone OttoboniGiulia GregoriNatalie di GeronimoMargherita OrtalliLazzarotto TizianaLuigi FontanaPublished in: Microorganisms (2024)
This study aims to report the efficacy of a combined intrastromal injection in optimizing the outcome of severe mycotic keratitis. Herein, we report a case series of 20 consecutive patients with positive fungal cultures not responding to topical antifungal treatment. Patients received cycles of intrastromal injections of voriconazole (50 µg/0.1 mL) and amphotericin B (2.5 µg/0.1 mL); all patients continued their topical antifungal therapy. The organisms isolated were Fusarium ( n = 5), Aspergillus ( n = 4), Candida ( n = 4), Rhodotorula ( n = 2), Penicillium ( n = 2), Alternaria ( n = 1), Bipolaris ( n = 1), and Curvularia ( n = 1). The size of the infiltrate varied from 6.5 to 1.5 mm. At presentation, the best corrected visual acuity (BCVA, namely, the best visual acuity achieved with glasses, if needed) was less than 20/400 in all patients, improving to better than 20/400 in eleven patients. Seven patients required surgical intervention; four of them underwent penetrating keratoplasty (PK) à chaud one month after the first intrastromal injection. Patients who underwent surgery achieved a BCVA of 20/40 or better. Combined intrastromal injections before therapeutic penetrating keratoplasty (TPK) effectively reduced ulcer size and graft diameter, preventing infection recurrence. Our results highlight the efficacy of combined intrastromal injections in optimizing outcomes for severe mycotic keratitis undergoing TPK.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- randomized controlled trial
- peritoneal dialysis
- type diabetes
- stem cells
- minimally invasive
- metabolic syndrome
- bone marrow
- pseudomonas aeruginosa
- staphylococcus aureus
- cystic fibrosis
- skeletal muscle
- early onset
- candida albicans
- wound healing
- patient reported
- atrial fibrillation
- gram negative